Approval · Notice of Compliance 36618 · 2011
ACTONEL DR: Notice of Compliance 36618
Issued July 19, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36618
- Date
- July 19, 2011
- Company
- Warner Chilcott Canada CoMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Dosage Form; Delayed-Release Tablet
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTONEL DR | 02370417 | Marketed |
Medicinal ingredients
- RISEDRONATE SODIUM 35 MG per TAB